$1.51 Billion is the total value of ARMISTICE CAPITAL, LLC's 66 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 58.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Sell | SPDR S&P 500 ETF TRput | $237,416,000 | -40.0% | 8,000 | -99.4% | 15.74% | -36.9% |
HAIN | Sell | HAIN CELESTIAL GROUP INCcall | $36,508,000 | -16.6% | 17,000 | -99.2% | 2.42% | -12.4% |
WBT | Sell | WELBILT INC | $35,271,000 | -3.6% | 2,092,000 | -4.6% | 2.34% | +1.3% |
ENR | Sell | ENERGIZER HLDGS INC NEW | $34,864,000 | -33.1% | 800,000 | -40.7% | 2.31% | -29.6% |
FTDR | Sell | FRONTDOOR INC | $19,039,000 | -12.6% | 392,000 | -21.6% | 1.26% | -8.1% |
ATRS | Sell | ANTARES PHARMA INC | $18,812,000 | -4.7% | 5,624,000 | -6.3% | 1.25% | +0.2% |
UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $18,343,000 | -27.5% | 230,000 | -29.0% | 1.22% | -23.7% |
QSR | Sell | RESTAURANT BRANDS INTL INC | $12,805,000 | +0.6% | 180,000 | -1.6% | 0.85% | +5.9% |
LOW | Sell | LOWES COS INC | $12,755,000 | -63.1% | 116,000 | -66.2% | 0.84% | -61.3% |
MNKKQ | Sell | MALLINCKRODT PUB LTD COcall | $9,640,000 | -70.8% | 40,000 | -98.9% | 0.64% | -69.3% |
MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $9,312,000 | -78.2% | 108,000 | -73.5% | 0.62% | -77.1% |
CLVS | Sell | CLOVIS ONCOLOGY INCcall | $7,860,000 | -76.1% | 20,000 | -99.1% | 0.52% | -74.9% |
PRTK | Sell | PARATEK PHARMACEUTICALS INC | $6,791,000 | -31.3% | 1,572,000 | -36.6% | 0.45% | -27.8% |
AMZN | Sell | AMAZON COM INC | $5,208,000 | -31.2% | 3,000 | -25.0% | 0.34% | -27.8% |
ADMS | Sell | ADAMAS PHARMACEUTICALS INC | $2,742,000 | -83.6% | 536,000 | -80.1% | 0.18% | -82.7% |
DYNT | Sell | DYNATRONICS CORP | $1,309,000 | +37.8% | 536,000 | -6.9% | 0.09% | +45.0% |
BLPH | Sell | BELLEROPHON THERAPEUTICS INC | $427,000 | -75.1% | 885,000 | -69.1% | 0.03% | -74.1% |
ROX | Exit | CASTLE BRANDS INC | $0 | – | -1,000,000 | -100.0% | -0.03% | – |
ALRN | Exit | AILERON THERAPEUTICS INC | $0 | – | -1,200,000 | -100.0% | -0.05% | – |
MDGSW | Exit | MEDIGUS LTD*w exp 07/23/202 | $0 | – | -1,285,715 | -100.0% | -0.10% | – |
PLAY | Exit | DAVE & BUSTERS ENTMT INC | $0 | – | -50,000 | -100.0% | -0.13% | – |
BIG | Exit | BIG LOTS INC | $0 | – | -75,000 | -100.0% | -0.14% | – |
ZFGN | Exit | ZAFGEN INC | $0 | – | -2,178,000 | -100.0% | -0.16% | – |
TPR | Exit | TAPESTRY INC | $0 | – | -100,000 | -100.0% | -0.20% | – |
EYEG | Exit | EYEGATE PHARMACEUTICALS INC | $0 | – | -17,812,500 | -100.0% | -0.27% | – |
SBBP | Exit | STRONGBRIDGE BIOPHARMA PLC | $0 | – | -1,580,000 | -100.0% | -0.31% | – |
SPOT | Exit | SPOTIFY TECHNOLOGY S A | $0 | – | -48,000 | -100.0% | -0.44% | – |
SKX | Exit | SKECHERS U S A INCcl a | $0 | – | -252,000 | -100.0% | -0.50% | – |
GOOS | Exit | CANADA GOOSE HOLDINGS INC | $0 | – | -218,000 | -100.0% | -0.53% | – |
KMX | Exit | CARMAX INC | $0 | – | -110,000 | -100.0% | -0.60% | – |
JACK | Exit | JACK IN THE BOX INC | $0 | – | -150,000 | -100.0% | -0.77% | – |
CLLS | Exit | CELLECTIS S Asponsored ads | $0 | – | -800,000 | -100.0% | -0.79% | – |
BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -100,000 | -100.0% | -0.80% | – |
PLNT | Exit | PLANET FITNESS INCcl a | $0 | – | -264,000 | -100.0% | -1.21% | – |
CPRX | Exit | CATALYST PHARMACEUTICALS INC | $0 | – | -5,000,000 | -100.0% | -1.21% | – |
FIVE | Exit | FIVE BELOW INC | $0 | – | -213,000 | -100.0% | -1.61% | – |
SJM | Exit | SMUCKER J M CO | $0 | – | -224,000 | -100.0% | -1.63% | – |
RH | Exit | RH | $0 | – | -224,000 | -100.0% | -1.63% | – |
BURL | Exit | BURLINGTON STORES INC | $0 | – | -224,000 | -100.0% | -2.40% | – |
EPC | Exit | EDGEWELL PERS CARE CO | $0 | – | -1,540,000 | -100.0% | -2.62% | – |
DFRG | Exit | DEL FRISCOS RESTAURANT GROUP | $0 | – | -6,125,000 | -100.0% | -3.07% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
INCYTE CORP | 21 | Q3 2023 | 2.8% |
VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.